Brief Introduction of Generic Drug Registration System
in 10 ASEAN Countries

亚洲社会药学

• Drug Economy • 上一篇下一篇

Brief Introduction of Generic Drug Registration System in 10 ASEAN Countries

Zhi Ying, Yang Yue*

School?of?Business?Administration,?Shenyang?Pharmaceutical?University,?Shenyang?110016,?China

出版日期:2016-06-20 发布日期:2016-07-19

Brief Introduction of Generic Drug Registration System in 10 ASEAN Countries

Zhi Ying, Yang Yue*

School?of?Business?Administration,?Shenyang?Pharmaceutical?University,?Shenyang?110016,?China

Online:2016-06-20 Published:2016-07-19
Contact: Yang Yue, professor. Major research area: pharmacy administration. Tel: 13998236315, E-mail: yyue315@126.com

摘要/Abstract

摘要： Objective To summarize the registration characteristics of generic drugs in 10 Association of Southeast Asian Nations countries and to put forward some suggestions for pharmaceutical enterprises applying for generic drug registration with these countries. Methods Literature review and comparative analysis were conducted to study generic drug regulatory authorities, laws and regulations, registration process and registration documentation requirements in the 10 ASEAN countries. Results and Conclusion For drug regulatory authorities, Singapore and Indonesia have one level of setting; Thailand, Vietnam, Philippines, Cambodia, Brunei and Laos have two levels of setting; Malaysia and Myanmar have three levels of setting. The registration procedure contains preparation, submission, review, evaluation and the approval from regulatory authorities. The generic drug registration documents for the 10 countries must be in accordance with the ASEAN CTD. Chinese pharmaceutical enterprises should be familiar with generic drug registration laws and regulations, and the process in ASEAN countries so that they can accelerate the registration process and improve the success rate.

关键词: ASEAN (Association of Southeast Asian Nations), generic drug, registration

Abstract: Objective To summarize the registration characteristics of generic drugs in 10 Association of Southeast Asian Nations countries and to put forward some suggestions for pharmaceutical enterprises applying for generic drug registration with these countries. Methods Literature review and comparative analysis were conducted to study generic drug regulatory authorities, laws and regulations, registration process and registration documentation requirements in the 10 ASEAN countries. Results and Conclusion For drug regulatory authorities, Singapore and Indonesia have one level of setting; Thailand, Vietnam, Philippines, Cambodia, Brunei and Laos have two levels of setting; Malaysia and Myanmar have three levels of setting. The registration procedure contains preparation, submission, review, evaluation and the approval from regulatory authorities. The generic drug registration documents for the 10 countries must be in accordance with the ASEAN CTD. Chinese pharmaceutical enterprises should be familiar with generic drug registration laws and regulations, and the process in ASEAN countries so that they can accelerate the registration process and improve the success rate.

Key words: ASEAN (Association of Southeast Asian Nations), generic drug, registration

. Brief Introduction of Generic Drug Registration System in 10 ASEAN Countries [J]. 亚洲社会药学.

[1]	Cao Yizhi, Lian Guiyu. Comparison and Suggestions on the Registration and Regulation of Biosimilars between China and the USA[J]. 亚洲社会药学, 2025, 20(1): 28-37.
[2]	Li Yuan, Wang Yijie, Wang Shuling. Research Progress and Suggestions on China’s Drug Registration Management Based on CiteSpace Knowledge Maps [J]. 亚洲社会药学, 2024, 19(3): 216-224.
[3]	Li Siwen , Yang Yue. The Impact of Generic Drug Consistency Evaluation Policy on Pharmaceutical Enterprises [J]. 亚洲社会药学, 2022, 17(2): 104-114.
[4]	Su Na , Tian Lijuan. Analysis and Enlightenment of Pediatric Drug Registration Data in China[J]. 亚洲社会药学, 2022, 17(1): 34-38.
[5]	Wang Hongwei, Yang Yue. Research and Reference of the Authorized Generic Drug System in the US[J]. 亚洲社会药学, 2021, 16(1): 11-22.
[6]	Zhang Tianqi, Chen Yuwen. Research on the World’s Most Valuable Antihypertensive Drugs Based on Patent Analysis[J]. 亚洲社会药学, 2021, 16(1): 76-83.
[7]	Chen Yuan, Chen Yuwen. Analysis on the Development Strategy of China’s Pharmaceutical Enterprises under the Background of Volume Procurement[J]. 亚洲社会药学, 2020, 15(4): 193-197.
[8]	Zheng Yongxia, Yang Yue. Discussion on Drug Procurement with Target Quantity in China and Its Problem[J]. 亚洲社会药学, 2019, 14(2): 59-65.
[9]	Huang Yufeng, Luo Suping, Yuan Hongmei. Research on Drug-Patent Linkage System under the New Situation[J]. 亚洲社会药学, 2019, 14(1): 7-14.
[10]	Mao Xiaofang, Qi Xiang, Zhou Fengxiang. Project Management of Generic Drug R&D and Registration in the United States[J]. 亚洲社会药学, 2018, 13(4): 113-123.
[11]	Liu Dandan, Chen Yuwen. Analysis of New Drug Registration for Biological Products from 2010 to 2015 in China[J]. 亚洲社会药学, 2017, 12(2): 57-63.
[12]	Liu yue, Sun Lihua. Introduction of Drug Re-evaluation in Foreign Countries and Its Enlightenment to China [J]. 亚洲社会药学, 2017, 12(1): 16-21.
[13]	ZHAO Jun-rui;NI Jing-yun;SI TOU Ka-weng;HU Yuan-jia*. Drug Registration and Approval System in China: CurrentStatus, Controversies and Future Perspectives[J]. , 2015, 10(4): 187-196.
[14]	LI Fei;BI Kai-shun. Analysis and Evaluation of Measures for the Administrationof Medical Device Registration[J]. , 2015, 10(3): 123-129.
[15]	WEN Qi;LI Jun-li;YU Pei-ming. Current Research Status of Atorvastatin Calcium[J]. , 2014, 9(1): 17-21.

亚洲社会药学

Brief Introduction of Generic Drug Registration System in 10 ASEAN Countries

Brief Introduction of Generic Drug Registration System in 10 ASEAN Countries

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价